Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Cocrystal Pharma Inc. diskutieren

Cocrystal Pharma Inc.

WKN: A3DWYX / Symbol: COCP / Name: Cocrystal Pharma / Aktie / Pharmazeutika / Small Cap /

0,89 €
-1,12 %

Einschätzung Buy
Rendite (%) -35,08 %
Kursziel 10,94
Veränderung
Endet am 11.08.24

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for COCP provided by MarketBeat

Einschätzung Buy
Rendite (%) -8,38 %
Kursziel 11,40
Veränderung
Endet am 04.10.24

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for COCP provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,25 %
Kursziel 11,05
Veränderung
Endet am 04.12.24

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for COCP provided by MarketBeat

Einschätzung Buy
Rendite (%) 42,48 %
Kursziel 9,16
Veränderung
Endet am 03.01.25

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $12.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for COCP provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,06 %
Kursziel 9,22
Veränderung
Endet am 20.03.25

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for COCP provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,52 %
Kursziel 9,20
Veränderung
Endet am 04.04.25

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for COCP provided by MarketBeat

Einschätzung Buy
Rendite (%) -25,15 %
Kursziel 9,25
Veränderung
Endet am 14.05.25

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for COCP provided by MarketBeat

Einschätzung Buy
Rendite (%) -20,61 %
Kursziel 6,29
Veränderung
Endet am 22.08.25

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $10.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for COCP provided by MarketBeat

Einschätzung Buy
Rendite (%) -51,64 %
Kursziel 6,71
Veränderung
Endet am 22.01.26

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Ratings data for COCP provided by MarketBeat

Einschätzung Buy
Rendite (%) -31,92 %
Kursziel 5,21
Veränderung
Endet am 20.06.26

Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for COCP provided by MarketBeat